Page 831 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 34 Miscellaneous Tumors 809

493. Ricklin ME, Roosje P, Summerfield A: Characterization of canine 517. Faller M, Lamm C, Affolter VK, et al.: Retrospective characterisa-
dendritic cells in healthy, atopic, and non-allergic inflamed skin, tion of solitary cutaneous histiocytoma with lymph node metastasis
J Clin Immunol 30:845–854, 2010. in eight dogs, J Small Anim Pract 57:548–552, 2016.
VetBooks.ir 494. Scalapino KJ, Daikh DI: CTLA-4: a key regulatory point in the 518. Mays MB, Bergeron JA: Cutaneous histiocytosis in dogs, J Am Vet
Med Assoc 188:377–381, 1986.
control of autoimmune disease, Immunol Rev 223:143–155, 2008.
495. Banchereau J, Steinman RM: Dendritic cells and the control of
immunity, Nature 392:245–252, 1998. 519. Palmeiro BS, Morris DO, Goldschmidt MH, et al.: Cutaneous
reactive histiocytosis in dogs: a retrospective evaluation of 32 cases,
496. Banchereau J, Briere F, Caux C, et al.: Immunology of dendritic Vet Dermatol 18:332–340, 2007.
cells, Ann Rev Immunol 18:767–811, 2000. 520. Scott DW, Angurano DK, Suter MM: Systemic histiocytosis in 2
497. Swerdlow SH, Campo E, et al.: WHO classification of tumors of dogs, Canine Pract 14:7–12, 1987.
the haematopoietic and lymphoid tissues, Lyon, 2008, International 521. Moore PF: Systemic histiocytosis of Bernese mountain dogs, Vet
Agency for Research on Cancer (IARC). Pathol 21:554–563, 1984.
498. Valli VEO: Histological classification of hematopoietic tumors 522. Scott DW, Miller WH, Griffin CE: Lymphohistiocytic neo-
of domestic animals. In Valli VEO, R Jacobs RM, et al.: World plasms. Muller and Kirk’s small animal dermatology, Philadelphia,
health organization international histological classification of tumors 2000, WB Saunders, pp 1130–1357.
of domestic animals, Washington, D.C., 2002, Armed Forces Insti- 523. Scherlie PH, Smedes SL, Feltz T, et al.: Ocular manifestations of
tute of Pathology, American Registry of Pathology. systemic histiocytosis in a dog, J Am Vet Med Assoc 201:1229, 1992.
499. Kato Y, Murakami M, Hoshino Y, et al.: The class A macrophage 524. DeHeer HL, Grindem CB: Histiocytic disorders. In Jaim NC, edi-
scavenger receptor CD204 is a useful immunohistochemical tor: Schalm’s veterinary hematology, ed 4, Philadelphia, 1986, Lea &
marker of canine histiocytic sarcoma, J Comp Pathol 148:188–196, Febiger, pp 696–702.
2013. 525. Moore PF: Malignant histiocytosis of Bernese mountain dogs, Vet
500. Marquet FM, Bonneau F, Pascale C, et al.: Characterization of Pathol 23:1–10, 1986.
dendritic cells subpopulations in skin and afferent lymph in the 526. Rosin A, Moore P, Dubielzig R: Malignant histiocytosis in Bernese
swine model, PLoS One 6:e16320, 2011. mountain dogs, J Am Vet Med Assoc 188:1041–1045, 1986.
501. Yi H, Guo C, Yu X, et al.: Targeting the immunoregulator SRA/ 527. Lenz JA, Furrow E, Craig LE, et al.: Histiocytic sarcoma in 14 min-
CD204 potentiates specific dendritic cell vaccine-induced T-cell iature schnauzers-a new breed predisposition? J Small Anim Pract
response and antitumor immunity, Cancer Res 71:6611–6620, 58:461–467, 2017.
2011. 528. Takahashi M, Tomiyasu H, Hotta E, et al.: Clinical characteristics
502. Ide T, Uchida K, Kagawa Y, et al.: Pathological and immunohisto- and prognostic factors in dogs with histiocytic sarcomas in Japan,
chemical features of subdural histiocytic sarcomas in 15 dogs, J Vet J Vet Med Sci 76:661–666, 2014.
Diagn Invest 23:127–132, 2011. 529. Voegeli E, Welle M, Hauser B, et al.: Histiocytic sarcoma in the
503. Schmidt JM, North SM, Freeman KP, et al.: Canine paediatric Swiss population of Bernese mountain dogs: a retrospective study
oncology: retrospective assessment of 9522 tumours in dogs up to of its genetic predisposition, Schweiz Arch Tierheilkd 148:281–288,
12 months (1993-2008), Vet Comp Oncol 8:283–292, 2010. 2006.
504. Glick AD, Holscher M, Campbell GR: Canine cutaneous histio- 530. Hedan B, Thomas R, Motsinger-Reif A, et al.: Molecular cytoge-
cytoma: ultrastructural and cytochemical observations, Vet Pathol netic characterization of canine histiocytic sarcoma: a spontaneous
13:374–380, 1976. model for human histiocytic cancer identifies deletion of tumor
505. Kelly DF: Canine cutaneous histiocytoma. A light and microscopic suppressor genes and highlights influence of genetic background on
study, Vet Pathol 7:12–27, 1970. tumor behaviour, BMC Cancer 11:201, 2011.
506. Bostock DE: Neoplasms of the skin and subcutaneous tissues in 531. Shearin AL, Hedan B, Cadieu E, et al.: The MTAP-CDKN2A
dogs and cats, Br Vet J 142:1–19, 1986. locus confers susceptibility to a naturally occurring canine cancer,
507. Rothwell TLW, Howlett CR, Middleton DJ, et al.: Skin neoplasms Cancer Epidemiol Biomarkers Prev 21:1019–1027, 2012.
of dogs in Sydney, Aust Vet J 64:161–164, 1987. 532. Thaiwong T, Sirivisoot S, Takada M, et al.: Gain-of-function muta-
508. Gross TL, Affolter VK: Advances in skin oncology. In Kwochka tion in PTPN11 in histiocytic sarcomas of Bernese mountain dogs,
KW, Willemse T, von Tscharner C, editors: Advances in veterinary Vet Comp Oncol 16:220–228, 2018.
dermatology, Oxford, UK, 1998, Butterworth-Heinmann, pp 382– 533. Manor EK, Craig LE, Sun X, et al.: Prior joint disease is associated
385. with increased risk of periarticular histiocytic sarcoma in dogs, Vet
509. Angus JC, de Lorimier LP: Lymphohistiocytic neoplasms. In Comp Oncol 16:E83–E88, 2018.
Campbell KL, editor: Small animal dermatology secrets, Philadel- 534. van Kuijk L, van Ginkel K, de Vos JP, et al.: Peri-articular histio-
phia, 2004, Hanley and Belfus, pp 425–442. cytic sarcoma and previous joint disease in Bernese mountain dogs,
510. Ramos-Vara JA, Miller MA: Immunohistochemical expression of J Vet Intern Med 27:293–299, 2013.
E-cadherin does not distinguish canine cutaneous histiocytoma 535. Constantino-Casas F, Mayhew D, Hoather TM, et al.: The clinical
from other canine round cell tumors, Vet Pathol 48:758–763, 2011. presentation and histopathologic–immunohistochemical classifica-
511. Baines SJ, McInnes EF, McConnell I: E-cadherin expression in tion of histiocytic sarcomas in the flat coated retriever, Vet Pathol
canine cutaneous histiocytomas, Vet Rec 162:509–513, 2008. 48:764–771, 2011.
512. Pires I, Queiroga FL, Alves A, Silva F, et al.: Decrease of E-cadherin 536. Erich SA, Constantino-Casas F, Dobson JM, et al.: Morphological
expression in canine cutaneous histiocytoma appears to be related distinction of histiocytic sarcoma from other tumor types in Ber-
to its spontaneous regression, Anticancer Res 29:2713–2717, 2009. nese mountain dogs and flatcoated retrievers, Vivo 32:7–17, 2018.
513. Schmitz L, Favara BE: Nosology and pathology of Langerhans cell 537. Dobson J, Hoather T, McKinley TJ, et al.: Mortality in a cohort of
histiocytosis, Hematol Oncol Clin North Am 12:221–246, 1998. flat-coated retrievers in the UK, Vet Comp Oncol 7:115–121, 2009.
514. Munn S, Chu AC: Langerhans cell histiocytosis of the skin, Hema- 538. Craig LE, Julian ME, Ferracone JD: The diagnosis and prognosis of
tol Oncol Clin North Am 12:269–286, 1998. synovial tumors in dogs: 35 cases, Vet Pathol 39:66–73, 2002.
515. Maina E, Colombo S, Stefanello D: Multiple cutaneous histiocy- 539. Hayden DW, Waters DJ, Burke BA, et al.: Disseminated malignant
tomas treated with lomustine in a dog, Vet Dermatol 25:559–599, histiocytosis in a golden retriever: clinicopathologic, ultrastructural,
2014. and immunohistochemical findings, Vet Pathol 30:256–264, 1993.
516. Nagata M, Hirata M, Ishida T, et al.: Progressive Langerhans’ cell 540. Kohn B, Arnold P, Kaser-Hotz B, et al.: Malignant histiocytosis of
histiocytosis in a puppy, Vet Dermatol 11:241–246, 2000. the dog: 26 cases (1989-1992), Kleintierpraxis 38:409–424, 1993.